Involvement of regucalcin as a suppressor protein in human carcinogenesis: insight into the gene therapy Masayoshi Yamaguchi Review – Cancer Research 18 September 2014 Pages: 1333 - 1341
HER2 positivity in gastric and esophageal adenocarcinoma: clinicopathological analysis and comparison T. KoopmanM. M. SmitsA. L. T. Imholz Original Article - Cancer Research 28 December 2014 Pages: 1343 - 1351
Circulating MACC1 as a novel diagnostic and prognostic biomarker for nonsmall cell lung cancer Zhiqiang WangMing CaiZongtao Xie Original Article – Cancer Research 28 December 2014 Pages: 1353 - 1361
Argininosuccinate synthetase (ASS) deficiency in high-grade pulmonary neuroendocrine carcinoma: an opportunity for personalized targeted therapy Ann E. WaltsJohn S. BomalaskiSandra Orsulic Original Article – Cancer Research 30 December 2014 Pages: 1363 - 1369
Osteopontin is a novel prognostic biomarker in early-stage non-small cell lung cancer after surgical resection Ci Hui YanMengguo LvXiubao Ren Original Article – Cancer Research 03 January 2015 Pages: 1371 - 1378
Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer Agnieszka Anna Rawłuszko-WieczorekAgnieszka SieraPaweł Piotr Jagodziński Original Article – Cancer Research Open access 04 January 2015 Pages: 1379 - 1392
Intronic and promoter polymorphisms of hMLH1/hMSH2 and colorectal cancer risk in Heilongjiang Province of China Guangxiao LiFulan HuYashuang Zhao Original Article – Cancer Research 06 January 2015 Pages: 1393 - 1404
Inhibition of heat shock protein 90 suppresses squamous carcinogenic progression in a mouse model of esophageal cancer Shaoxiang WangZhan DuXueyun Zhong Original Article – Cancer Research 07 January 2015 Pages: 1405 - 1416
Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung Hibiki UdagawaGenichiro IshiiYuichiro Ohe Original Article – Cancer Research 09 January 2015 Pages: 1417 - 1425
Should KRAS mutation still be used as a routine predictor of response to EGFR-TKIs in advanced non-small-cell lung cancer? A revaluation based on meta-analysis Min YingXiaoxia ZhuLonghua Chen Review – Clinical Oncology 11 January 2015 Pages: 1427 - 1439
Prognostic value of ABO blood group in patients with renal cell carcinoma: single-institution results from a large cohort Chunwoo LeeDalsan YouChoung-Soo Kim Original Article – Clinical Oncology 17 February 2015 Pages: 1441 - 1447
Perception of cancer patients of their disease, self-efficacy and locus of control and usage of complementary and alternative medicine Marie-Desirée EbelIvonne RudolphJutta Huebner Original Article – Clinical Oncology 22 February 2015 Pages: 1449 - 1455
Circulating tumor cells versus objective response assessment predicting survival in metastatic castration-resistant prostate cancer patients treated with docetaxel chemotherapy M. ThalgottM. M. HeckR. Nawroth Original Article – Clinical Oncology 24 February 2015 Pages: 1457 - 1464
The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin Shuai XiaoLongfei LiuMin Fang Original Article – Clinical Oncology 26 February 2015 Pages: 1465 - 1474
RETRACTED ARTICLE: The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer Cornelia BachmannSara Y. BruckerEva-Maria Grischke Original Article – Clinical Oncology 05 March 2015 Pages: 1475 - 1480
Adherence, exposure and patients’ experiences with the use of erlotinib in non-small cell lung cancer Lonneke TimmersChristel C. L. M. BoonsJacqueline G. Hugtenburg Original Article – Clinical Oncology Open access 06 March 2015 Pages: 1481 - 1491
Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip Jong Jin OhSeunghyun ParkSeok-Soo Byun Original Article – Clinical Oncology 13 March 2015 Pages: 1493 - 1501
Immunohistochemical expression of endoglin offers a reliable estimation of bone marrow neoangiogenesis in multiple myeloma Michael G. AlexandrakisIoannis K. NeonakisGeorge Tsirakis Original Article – Clinical Oncology 13 March 2015 Pages: 1503 - 1509